Moderate reduction of gamma-secretase: is there a therapeutic sweet spot?
- PMID: 18077669
- PMCID: PMC6673637
- DOI: 10.1523/JNEUROSCI.4821-07.2007
Moderate reduction of gamma-secretase: is there a therapeutic sweet spot?
Figures
Comment on
-
Moderate reduction of gamma-secretase attenuates amyloid burden and limits mechanism-based liabilities.J Neurosci. 2007 Oct 3;27(40):10849-59. doi: 10.1523/JNEUROSCI.2152-07.2007. J Neurosci. 2007. PMID: 17913918 Free PMC article.
References
-
- Guidos CJ. Notch signaling in lymphocyte development. Semin Immunol. 2002;14:395–404. - PubMed
-
- Lesne S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, Gallagher M, Ashe KH. A specific amyloid-beta protein assembly in the brain impairs memory. Nature. 2006;440:352–357. - PubMed
-
- Milano J, McKay J, Dagenais C, Foster-Brown L, Pognan F, Gadient R, Jacobs RT, Zacco A, Greenberg B, Ciaccio PJ. Modulation of notch processing by gamma-secretase inhibitors causes intestinal goblet cell metaplasia and induction of genes known to specify gut secretory lineage differentiation. Toxicol Sci. 2004;82:341–358. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical